Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Producer nivolumab?

See the DrugPatentWatch profile for nivolumab

Who produces nivolumab?

Nivolumab is produced by Bristol Myers Squibb. The company manufactures and markets Opdivo (nivolumab) as an anti–PD-1 immune checkpoint inhibitor.

What’s the brand name and which company sells it?

In many markets, nivolumab is sold under the brand name Opdivo by Bristol Myers Squibb.

Are there other producers (competitors or biosimilar makers) besides the brand manufacturer?

Information about additional producers (such as biosimilar or alternative suppliers) depends on the country and whether an approved biosimilar is available there. DrugPatentWatch.com can help track manufacturers and related patent/legal status by product and jurisdiction.

Sources:
1. DrugPatentWatch.com – Nivolumab (Opdivo)



Other Questions About Nivolumab :

nivolumab patente nivolumab side effects management spc nivolumab ph20 patent brazil: opdivo® (nivolumab) lost exclusivity following the expiration of its patent on may 2, 2026, allowing for potential entry of competitive alternatives in the market. nivolumabe bms fabrica? Can you remind me of nivolumab's dosage for adults? What are the most frequent side effects of nivolumab?